Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules : a comprehensive review
Bioactive compounds derived from plants have been investigated for treating various pathological conditions. However, the utilization of these compounds has challenges such as instability, low solubility and bioavailability. To overcome these challenges, the encapsulation of bioactive molecules with in a novel nano carrier system enabling effective delivery and clinical translation has become essential. Lipid-based nanocarriers provide versatile platforms for encapsulating and delivering bioactive compounds and overcome the challenges. These novel carriers can improve solubility, stability, improved drug retention and therapeutic efficacy of plant derived bioactive compounds. The current review evaluates the challenges in delivery of plant bioactives and highlights the potential of various lipid-based nano carriers designed to improve its therapeutic efficacy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Therapeutic delivery - 15(2024), 2 vom: 07. Feb., Seite 135-155 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kothapalli, Pavithra [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bioactive compounds |
---|
Anmerkungen: |
Date Completed 01.02.2024 Date Revised 09.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.4155/tde-2023-0116 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367046741 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367046741 | ||
003 | DE-627 | ||
005 | 20240209232041.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240114s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4155/tde-2023-0116 |2 doi | |
028 | 5 | 2 | |a pubmed24n1285.xml |
035 | |a (DE-627)NLM367046741 | ||
035 | |a (NLM)38214118 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kothapalli, Pavithra |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules |b a comprehensive review |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.02.2024 | ||
500 | |a Date Revised 09.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Bioactive compounds derived from plants have been investigated for treating various pathological conditions. However, the utilization of these compounds has challenges such as instability, low solubility and bioavailability. To overcome these challenges, the encapsulation of bioactive molecules with in a novel nano carrier system enabling effective delivery and clinical translation has become essential. Lipid-based nanocarriers provide versatile platforms for encapsulating and delivering bioactive compounds and overcome the challenges. These novel carriers can improve solubility, stability, improved drug retention and therapeutic efficacy of plant derived bioactive compounds. The current review evaluates the challenges in delivery of plant bioactives and highlights the potential of various lipid-based nano carriers designed to improve its therapeutic efficacy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a bioactive compounds | |
650 | 4 | |a enhanced bioavailability | |
650 | 4 | |a formulation and development | |
650 | 4 | |a lipid-based nanocarriers | |
650 | 4 | |a novel drug-delivery system | |
650 | 7 | |a Lipids |2 NLM | |
650 | 7 | |a Drug Carriers |2 NLM | |
700 | 1 | |a Vasanthan, Manimaran |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Therapeutic delivery |d 2010 |g 15(2024), 2 vom: 07. Feb., Seite 135-155 |w (DE-627)NLM203937082 |x 2041-6008 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2024 |g number:2 |g day:07 |g month:02 |g pages:135-155 |
856 | 4 | 0 | |u http://dx.doi.org/10.4155/tde-2023-0116 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2024 |e 2 |b 07 |c 02 |h 135-155 |